A comparative study of leukaemia inhibitory factor and interleukin-1α intracellular content in a human keratinocyte cell line after exposure to cosmetic fragrances and sodium dodecyl sulphate

Toxicology Letters

Volumn 192, Issue 2, 2010, Pages 101-107

  Parodi, Alessandro ^a,b   Sanguineti, Roberta ^a   Catalano, Mariafrancesca ^a   Penco, Susanna ^a   Pronzato, Maria Adelaide ^a   Scanarotti, Chiara ^a   Bassi, Anna Maria ^a  

^a Department of Experimental Medicine ^*  (Italy)

^b Advanced Biotechnology Centre   (Italy)

Author keywords

Human keratinocytes; IL 1 ; In vitro; LIF; Skin irritation

Indexed keywords

BENZYL ALCOHOL; DODECYL SULFATE SODIUM; FRAGRANCE; GERANIOL; INTERLEUKIN 1ALPHA; LEUKEMIA INHIBITORY FACTOR; LIMONENE;

ARTICLE; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; COSMETIC INDUSTRY; CYTOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; KERATINOCYTE; PRIORITY JOURNAL; SKIN IRRITATION; TOXICITY TESTING;

BENZYL ALCOHOL; BIOLOGICAL MARKERS; CELL LINE; CYCLOHEXENES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INTERLEUKIN-1ALPHA; KERATINOCYTES; LEUKEMIA INHIBITORY FACTOR; PERFUME; SKIN IRRITANCY TESTS; SODIUM DODECYL SULFATE; TERPENES;

ANIMALIA;

EID: 73749085581     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2009.10.013     Document Type: Article

References (45)

1. Asadullah K., Döcke W.-D., Volk H.-D., and Sterry W. The pathophysiological role of cytokines in psoriasis. Drugs Today 35 (1999) 913
2. Banner L.R., Patterson P.H., Allchorne A., Poole S., and Woolf C.J. Leukemia inhibitory factor is an anti-inflammatory and analgesic cytokine. J. Neurosci. 15; 18 14 (1998) 5456-5462
3. Baumann H., Jahreis G.P., Sauder D.N., and Koi A. Human keratinocytes and monocytes release factors which regulate the synthesis of major acute phase plasma proteins in hepatic cell from man, rat and mouse. J. Biol. Chem. 259 (1984) 7331-7342
4. Bonifati C., and Ameglio F. Cytokines in psoriasis. Int. J. Dermatol. 38 (1999) 241
5. Borenfreund E., Babik H., and Martin-Alguacil N. Comparison of two in vitro cytotoxicity assays-the neutral red (NR) and tetrazolium MTT tests. Toxicol. In Vitro 2 (1988) 1-6
6. Botham P.A. The validation of in vitro methods for skin irritation. Toxicol. Lett. 149 (2004) 387-390
7. Bulger R.E. Use of animals in experimental research: a scientist's perspective. Anat. Rec. 219 (1987) 215-220
8. Burlando B., Parodi A., Volante A., and Bassi A.M. Comparison of the irritation potentials of Boswellia serrata gum resin and of acetyl-11-keto-beta-boswellic acid by in vitro cytotoxicity tests on human skin-derived cell lines. Toxicol. Lett. 177 (2008) 144-149
9. Chen M. Amended final report of the safety assessment of t-Butyl Alcohol as used in cosmetics. Int. J. Toxicol. 24 Suppl. 2 (2005) 1-20
10. Corsini E., and Galli C. Epidermal cytokines in experimental contact dermatitis. Toxicol. 142 (2000) 203-211
11. Cotovio J., Grandidier M.H., Portes P., Roguet R., and Rubinstenn G. The in vitro acute skin irritation of chemicals: optimisation of the EPISKIN prediction model within the framework of the ECVAM validation process. Altern. Lab. Anim. 33 (2005) 329-349
12. Dinarello C.A. Proinflammatory cytokine. Chest 118 (2000) 503-508
13. Eun H.C., and Suth D.H. Comprehensive outlook of in vitro tests for assessing skin irritancy as alternatives to Draize tests. J. Dermatol. Sci. 24 (2000) 77-91
14. -/- mouse uterus. Biol. Reprod. 79 (2008) 142-153
15. Gadient R., and Patterson P.H. Leukemia inhibitory factor, interleukin 6, and other cytokines using the GP130 transducing receptor: roles in inflammation and injury. Stem Cells 17 (1999) 127-137
16. Gearing D.P. The Leukaemia inhibitory and its receptor. Adv. Immunol. 53 (1993) 51-58
17. Gibbs S. In vitro irritation models and immune reactions. Skin Pharmacol. Physiol. 22 (2009) 103-113
18. Grandjean-Laquerriere A., Antonicelli F., Gangloff S.C., Guenounou M., and Le Naour R. UVB-induced IL-18 production in human keratinocyte cell line NCTC 2544 through NF-kappaB activation. Cytokine 37 (2007) 76-83
19. Grandjean-Laquerriere A., Le Naour R., Gangloff S.C., and Guenounou M. Differential regulation of TNF-alpha, IL-6 and IL-10 in UVB-irradiated human keratinocytes via cyclic AMP/protein kinase A pathway. Cytokine 23 (2003) 138-149
20. Grandjean-Laquerriere A., Le Naour R., Gangloff S.C., and Guenounou M. Contribution of protein kinase A and protein kinase C pathways in ultraviolet B-induced IL-8 expression by human keratinocytes. Cytokine 29 (2005) 197-207
21. Heinrich P.C., Behrmann I., Haan S., Hermanns H.M., Müller-Newen G., and Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 374 Pt 1 (2003) 1-20
22. Laemmli U.K. Cleavage of structural proteins during the assembly of the head bacteriophage T4. Nature 227 (1970) 680-685
23. Lee E., An S., Choi D., Moon S., and Chang I. Comparison of objective and sensory skin irritations of several cosmetic preservatives. Contact Dermat. 56 (2007) 131-136
24. Lennet E.D.A. An improved mounting medium for immunofluorescence microscopy. Am. J. Clin. Pathol. 69 (1978) 647-648
25. Lotz M., Moats T., and Villiger P.M. Leukaemia inhibitory factor s expressed in cartilage and synovium and can contribute to the pathogenesis of arthritis. J. Clin. Invest. 90 (1992) 888-896
26. Martinez V., Corsini E., Mitjans M., Pinazo A., and Vinardell M.P. Evaluation of eye and skin irritation of arginine-derivative surfactants using different in vitro endpoints as alternatives to the in vivo assays. Toxicol. Lett. 164 (2006) 259-267
27. McKenzie R.C., and Szepietowski J.C. Leukaemia inhibitory factor (LIF) expression in skin from amyotrophic lateral sclerosis patients compared with skin from normal individuals: what is the function of LIF in the skin?. J. Invest. Dermatol. 116 (2001) 476-478
28. McKenzie R.C., and Szepietowski J. Cutaneous leukemia inhibitory factor and its potential role in the development of skin tumors. Dermatol. Surg. 30 (2004) 279-290
29. Mori M., Yamaguchi K., Honda S., Nagasaki K., Veda M., Abe O., and Abe K. Cancer cachexia syndrome developed in nude mice bearing melanoma cells producing Leukaemia inhibitory factor. Cancer Res. 51 (1991) 6656-6659
30. Mosman T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 63 (1983) 55-63
31. Paglia D., Kondo S., Ng K.M., Sauder D.N., and McKenzie R.C. Leukaemia inhibitory factor is expressed by normal human keratinocytes in vitro and in vivo. Br. J. Dermatol. 134 (1996) 817-823
32. Riddell R.J., Clothier R.H., and Balls M. An evaluation of three in vitro cytotoxicity assays. Food Chem. Toxicol. 24 (1986) 469-471
33. Russell W.M. The development of the three Rs concept. Altern. Lab Anim. 23 3 (1995) 298-304
34. Sanchez L., Mitjans M., Infante M.R., and Vinardell M.P. Assessment of the potential skin irritation of lysine derivate anionic surfactants using mouse fibroblasts and human keratinocytes as an alternative to animal testing. Pharm. Res. 21 (2004) 1637-1641
35. Sanchez L., Mitjans M., Infante M.R., and Vinardell M.P. Determination of interleukin-1alpha in human NCTC 2544 keratinocyte cells as a predictor of skin irritation from lysine-based surfactants. Toxicol. Lett. 167 (2006) 40-46
36. Spielmann H., Hoffmann S., Liebsch M., Botham P., Fentem J., Eskes C., Roguet R., Cotovió J., Cole T., Worth A., Heylings J., Jones P., Robles C., Kandárová H., Gamer A., Remmele M., Curren R., Raabe H., Cockshott A., Gerner I., and Zuang V. The ECVAM international validation study on in vitro tests for acute skin irritation: report on the validity of the EPISKIN and EpiDerm Assays and on the Skin Integrity Function Test. Altern. Lab. Anim. 35 (2007) 559-601
37. Szepietowski J.C., McKenzie R.C., Keohane S.G., Walker C., Aldrgige R.D., and Hunter J.A.A. Leukaemia inhibitory factor induction in early phase of allergic contact dermatitis. Contact Dermat. 36 (1997) 21-25
38. Tomida M., Yamamoto-Yamaguchi Y., and Hozumi M. Purification of a factor inducing differentiation of mouse myeloid leukemic M1 cells from conditioned medium of mouse fibroblasts L929 cells. J. Biol. Chem. 259 (1984) 10978-10982
39. Ullrich S.E. The role of epidermal cytokines in the generation of cutaneous immune-reactions and ultraviolet radiation-induced immune suppression. Photochem. Photobiol. 62 (1995) 389
40. Villiger P.M., Geng Y., and Lotz M. Induction of cytokine expression by leukaemia inhibitory factor. J. Clin. Invest. 90 (1992) 888-896
41. Waring P., Wycherley K., Cary D., Nicola N., and Metcalf D. Leukaemia inhibitory factor levels are elevated in septic shock and various inflammatory body fluids. J. Clin. Invest. 90 (1992) 2031-2037
42. Werman A., Werman-Venkert R., White R., Lee J.K., Werman B., Krelin Y., Voronov E., Dinarello C.A., and Apte R.N. The precursor form of IL-1(alpha) is an intracrine proinflammatory activator of transcription. PNAS 101 (2004) 2434-2439
43. Wilmer J.L., Burleson F.G., Kayama F., Kanno J., and Luster M.I. Cytokine induction in human epidermal keratinocytes exposed to contact irritants and its relation to chemical-induced inflammation in mouse skin. J. Invest. Dermatol. 102 (1994) 915-922
44. York M., Griffiths H.A., Whittle E., and Basketter D.A. Evaluation of a human patch test for the identification and classification of skin irritation potential. Contact Dermat. (1996) 204-212
45. Zhu M., Oishi K., Lee S.C., and Patterson P.H. Studies using leukemia inhibitory factor (LIF) knockout mice and a LIF adenoviral vector demonstrate a key anti-inflammatory role for this cytokine in cutaneous inflammation. J. Immunol. 1 166 (2001) 2049-2054